Literature DB >> 19870145

AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS.

H K Ward1, J F Enders.   

Abstract

1. In normal unheated human serum, virulent pneumococci may be prepared for phagocytosis by two separate antibodies, acting in conjunction with complement. One of these is the type-specific anticarbohydrate antibody reacting with the carbohydrate fraction of the pneumococcus. The other is probably also a type-specific antibody, but quite distinct from the former, and therefore must react with a different antigenic constituent of the bacterium. 2. In the normal human serum heated to 56 degrees C., these two antibodies may, after prolonged contact with the organism, promote phagocytosis of the pneumococcus without the adjuvant action of complement. 3. Although these two antibodies are equally effective in the phagocytosis of 24 hour culture organisms by normal blood, the anticarbohydrate antibody tends to become the predominant factor as the pneumococci approach the state in which they exist in the animal body. 4. In so far as we have been able to show, the anticarbohydrate antibody is the only antibody in immune serum which can induce phagocytosis. This substance by itself is active in a phagocytic system, but just as in the normal serum, complement enhances its effect. The failure to demonstrate the presence in the immune serum of an antibody, distinct from the anticarbohydrate antibody, analogous to that found in the normal serum, may be due to the experimental difficulty of removing all the anticarbohydrate antibody from a concentrated immune serum. 5. Thus it is seen that a single well defined antibody (the anticarbohydrate antibody) may be responsible for the phagocytic action of normal unheated serum, normal heated serum, inactivated immune serum, and immune serum activated by complement. These facts appear to us to invalidate Neufeld's division of the phagocytic antibodies into (a) bacteriotropins (antibodies, the phagocytic titre of which is not raised by the addition of complement); (b) opsonic antibodies (antibodies, comparable to the lysins, which are only active in the presence of complement). 6. Complement alone is incapable of inducing phagocytosis of the pneumococcus. In the phagocytic process, it appears simply to increase the speed at which the reaction takes place. Its role may be compared to that of a catalyst in a chemical reaction. 7. On the basis of these findings, it is proposed that the term "tropin" be discarded as misleading and unnecessary, and that the term "opsonin" be retained to denote any heat-stable antibody which prepares bacteria for phagocytosis. Contrary to current usage, it would not suggest a combination of antibody with complement.

Entities:  

Year:  1933        PMID: 19870145      PMCID: PMC2132244          DOI: 10.1084/jem.57.4.527

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  The Separation of Opsonic Amboceptor and Complement in the Cold.

Authors:  W S Chapin; D M Cowie
Journal:  J Med Res       Date:  1907-11

2.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.

Authors:  R H Sia
Journal:  J Exp Med       Date:  1926-04-30       Impact factor: 14.307

3.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.

Authors:  M Heidelberger; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

4.  ON THE MECHANISM OF OPSONIN AND BACTERIOTROPIN ACTION : VI. AGGLUTINATION AND TROPIN ACTION BY PRECIPITIN SERA. CHARACTERIZATION OF THE SENSITIZED SURFACE.

Authors:  S Mudd; B Lucké; M McCutcheon; M Strumia
Journal:  J Exp Med       Date:  1930-08-31       Impact factor: 14.307

5.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VII. THE RELATION OF OPSONINS TO NATURAL RESISTANCE AGAINST PNEUMOCOCCUS INFECTION.

Authors:  O H Robertson; R H Sia
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

6.  AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : I. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND THE PURIFIED SPECIFIC CARBOHYDRATE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1932-03-31       Impact factor: 14.307

7.  OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD : I. THE NORMAL PHAGOCYTIC TITRE, AND THE ANTI-PHAGOCYTIC EFFECT OF THE SPECIFIC SOLUBLE SUBSTANCE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1930-04-30       Impact factor: 14.307

  7 in total
  31 in total

1.  The opsonic activity of complement in sera without antibody.

Authors:  J STERZL
Journal:  Folia Microbiol (Praha)       Date:  1963-07       Impact factor: 2.099

2.  Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G.

Authors:  C W Cutler; J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  A Multiparametric and High-Throughput Assay to Quantify the Influence of Target Size on Phagocytosis.

Authors:  Lorraine Montel; Léa Pinon; Jacques Fattaccioli
Journal:  Biophys J       Date:  2019-06-26       Impact factor: 4.033

4.  [Phagocytic function of polymorphonuclear leucocytes in psoriatic inflammation (author's transl)].

Authors:  K Bork; H Holzmann
Journal:  Arch Dermatol Forsch       Date:  1974

5.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Measurement of chemiluminescence in freshly drawn human blood. I. Role of granulocytes, platelets, and plasma factors in zymosan-induced chemiluminescence.

Authors:  T Kato; H Wokalek; E Schöpf; H Eggert; M Ernst; E T Rietschel; H Fischer
Journal:  Klin Wochenschr       Date:  1981-03-02

7.  Nitroblue tetrazolium-dye reduction by rat peritoneal macrophages during the uptake of Diplococcus pneumoniae, type VI.

Authors:  H A Drexhage; R D van der Gaag; F Namavar
Journal:  Antonie Van Leeuwenhoek       Date:  1978       Impact factor: 2.271

8.  The Role of Dendritic Cells in S. pneumoniae Transport to Follicular Dendritic Cells.

Authors:  Balthasar A Heesters; Michael C Carroll
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

9.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

10.  Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.

Authors:  A B Bjornson; J S Lobel
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.